Novo Nordisk's Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease
TLDR
#Corporate Announcements
By PRNewsWire•August 31, 2025•5 min read
WANT YOUR STARTUP FEATURED ON THE TECH BUZZ?
The tech world's most engaged audience
GET FEATUREDAward-winning (Hackernoon)
CES Media Partner
1.1M
Subscribers
56.24%
Avg Open Rate
60+
Brand Placements
#1
Most Engaged
From PRNewsWire•Corporate Announcements